Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 10 | 2018 | 3578 | 0.850 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2017 | 125 | 0.640 |
Why?
|
| Fusobacterium Infections | 1 | 2017 | 28 | 0.600 |
Why?
|
| Chemokine CCL20 | 1 | 2017 | 39 | 0.600 |
Why?
|
| Fusobacterium nucleatum | 1 | 2017 | 35 | 0.590 |
Why?
|
| Pseudogenes | 1 | 2015 | 81 | 0.520 |
Why?
|
| Monocytes | 1 | 2017 | 788 | 0.450 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2013 | 430 | 0.400 |
Why?
|
| Receptors, Ghrelin | 2 | 2021 | 35 | 0.390 |
Why?
|
| Thermogenesis | 2 | 2021 | 46 | 0.390 |
Why?
|
| Prostatic Neoplasms | 9 | 2011 | 5767 | 0.390 |
Why?
|
| Organoplatinum Compounds | 1 | 2013 | 702 | 0.380 |
Why?
|
| Carcinogenesis | 1 | 2017 | 1026 | 0.380 |
Why?
|
| Exophiala | 2 | 2000 | 2 | 0.380 |
Why?
|
| Bone Neoplasms | 5 | 2011 | 2576 | 0.340 |
Why?
|
| Adenosine Triphosphatases | 1 | 2011 | 435 | 0.330 |
Why?
|
| Receptor, ErbB-3 | 4 | 2008 | 122 | 0.300 |
Why?
|
| Neoplastic Stem Cells | 4 | 2018 | 1443 | 0.290 |
Why?
|
| Adenocarcinoma | 2 | 2017 | 7789 | 0.270 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2017 | 1533 | 0.270 |
Why?
|
| Cell Movement | 5 | 2017 | 2466 | 0.260 |
Why?
|
| MicroRNAs | 2 | 2015 | 2947 | 0.230 |
Why?
|
| Genes, Fungal | 2 | 2000 | 84 | 0.230 |
Why?
|
| Phenotype | 5 | 2018 | 6295 | 0.210 |
Why?
|
| Cadherins | 3 | 2010 | 660 | 0.210 |
Why?
|
| cdc42 GTP-Binding Protein, Saccharomyces cerevisiae | 1 | 2000 | 4 | 0.190 |
Why?
|
| Genetic Vectors | 3 | 2002 | 1694 | 0.190 |
Why?
|
| Receptors, Androgen | 2 | 2010 | 878 | 0.190 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2000 | 42 | 0.190 |
Why?
|
| Adipose Tissue, Brown | 1 | 2021 | 112 | 0.190 |
Why?
|
| Cell Line, Tumor | 8 | 2017 | 14551 | 0.180 |
Why?
|
| Transformation, Genetic | 1 | 1999 | 57 | 0.180 |
Why?
|
| Transgenes | 1 | 2002 | 557 | 0.180 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 1999 | 108 | 0.170 |
Why?
|
| Osteoblasts | 3 | 2010 | 370 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2016 | 8873 | 0.170 |
Why?
|
| Adenoviridae | 2 | 2002 | 1459 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2016 | 5178 | 0.160 |
Why?
|
| Publications | 1 | 2018 | 54 | 0.160 |
Why?
|
| ADAM Proteins | 2 | 2016 | 134 | 0.160 |
Why?
|
| Ethics, Research | 1 | 2018 | 67 | 0.160 |
Why?
|
| Coculture Techniques | 2 | 2017 | 626 | 0.150 |
Why?
|
| Gene Transfer Techniques | 1 | 2000 | 716 | 0.150 |
Why?
|
| RNA, Bacterial | 1 | 2017 | 80 | 0.150 |
Why?
|
| Genetic Therapy | 2 | 2002 | 1616 | 0.150 |
Why?
|
| Macrophage Activation | 1 | 2017 | 148 | 0.150 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 208 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 5 | 2017 | 3981 | 0.140 |
Why?
|
| Transcription Factors | 2 | 2012 | 5270 | 0.140 |
Why?
|
| Adipose Tissue | 1 | 2021 | 769 | 0.140 |
Why?
|
| Th17 Cells | 1 | 2017 | 162 | 0.130 |
Why?
|
| Androgens | 2 | 2010 | 511 | 0.130 |
Why?
|
| Heterografts | 2 | 2015 | 733 | 0.130 |
Why?
|
| RNA, Antisense | 1 | 2015 | 69 | 0.130 |
Why?
|
| Research | 1 | 2018 | 415 | 0.130 |
Why?
|
| Insulin Resistance | 1 | 2021 | 731 | 0.130 |
Why?
|
| Interleukin-17 | 1 | 2017 | 250 | 0.130 |
Why?
|
| Endodeoxyribonucleases | 3 | 2001 | 105 | 0.130 |
Why?
|
| Hedgehog Proteins | 1 | 2018 | 424 | 0.130 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 490 | 0.130 |
Why?
|
| Interleukins | 1 | 2017 | 325 | 0.130 |
Why?
|
| Fluorouracil | 2 | 2016 | 1944 | 0.130 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 218 | 0.120 |
Why?
|
| Cell Proliferation | 4 | 2016 | 7226 | 0.120 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2013 | 16 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 3343 | 0.120 |
Why?
|
| Bone and Bones | 2 | 2007 | 619 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 651 | 0.120 |
Why?
|
| DNA Primers | 3 | 2008 | 1399 | 0.120 |
Why?
|
| Animals | 16 | 2021 | 59536 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 1217 | 0.110 |
Why?
|
| Neoplasm Proteins | 2 | 2017 | 3230 | 0.110 |
Why?
|
| Mice, Nude | 3 | 2015 | 4307 | 0.110 |
Why?
|
| Antineoplastic Agents | 3 | 2013 | 14289 | 0.100 |
Why?
|
| Bone Marrow | 2 | 2011 | 2358 | 0.100 |
Why?
|
| Katanin | 1 | 2011 | 5 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 1538 | 0.100 |
Why?
|
| Macrophages | 1 | 2018 | 1304 | 0.100 |
Why?
|
| Osteonectin | 2 | 2010 | 53 | 0.100 |
Why?
|
| Rectum | 1 | 2013 | 467 | 0.100 |
Why?
|
| Cell Communication | 2 | 2013 | 509 | 0.100 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 1081 | 0.100 |
Why?
|
| Mifepristone | 2 | 2002 | 147 | 0.100 |
Why?
|
| Mice | 13 | 2021 | 34495 | 0.100 |
Why?
|
| Camptothecin | 1 | 2013 | 517 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2017 | 973 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2013 | 2074 | 0.090 |
Why?
|
| Humans | 25 | 2018 | 261506 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 1 | 2013 | 545 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2010 | 79 | 0.090 |
Why?
|
| Male | 14 | 2021 | 123000 | 0.090 |
Why?
|
| Colon | 1 | 2013 | 670 | 0.090 |
Why?
|
| Receptors, Notch | 1 | 2013 | 383 | 0.090 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 650 | 0.090 |
Why?
|
| Diet, High-Fat | 2 | 2021 | 241 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 852 | 0.080 |
Why?
|
| Culture Media, Conditioned | 3 | 2018 | 260 | 0.080 |
Why?
|
| Base Sequence | 4 | 2008 | 4917 | 0.080 |
Why?
|
| Obesity | 1 | 2021 | 2884 | 0.080 |
Why?
|
| DNA Adducts | 2 | 2001 | 210 | 0.080 |
Why?
|
| Mice, Transgenic | 3 | 2010 | 4143 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2000 | 997 | 0.080 |
Why?
|
| Escherichia coli Proteins | 3 | 2001 | 359 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2018 | 3639 | 0.080 |
Why?
|
| Bone Development | 1 | 2008 | 83 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2011 | 2450 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 6009 | 0.080 |
Why?
|
| Disease Progression | 2 | 2017 | 6682 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2015 | 6150 | 0.070 |
Why?
|
| src-Family Kinases | 1 | 2010 | 478 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2013 | 1048 | 0.070 |
Why?
|
| Prostate | 1 | 2011 | 1088 | 0.070 |
Why?
|
| HT29 Cells | 2 | 2017 | 159 | 0.070 |
Why?
|
| Thiazoles | 1 | 2010 | 726 | 0.070 |
Why?
|
| Protein Isoforms | 3 | 2007 | 842 | 0.070 |
Why?
|
| Lac Operon | 1 | 2005 | 122 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2016 | 3536 | 0.070 |
Why?
|
| Crosses, Genetic | 1 | 2005 | 241 | 0.060 |
Why?
|
| ADAM17 Protein | 2 | 2016 | 15 | 0.060 |
Why?
|
| Apoptosis | 2 | 2016 | 7591 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2001 | 6089 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 4 | 2016 | 5395 | 0.060 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2005 | 236 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 3 | 2013 | 1077 | 0.060 |
Why?
|
| Luciferases | 1 | 2005 | 445 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2013 | 1764 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2000 | 4233 | 0.060 |
Why?
|
| Neoplasm Staging | 2 | 2017 | 13658 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2021 | 5710 | 0.060 |
Why?
|
| Gene Expression | 3 | 2013 | 3570 | 0.060 |
Why?
|
| Biopsy | 1 | 2011 | 3443 | 0.060 |
Why?
|
| Histone Acetyltransferases | 1 | 2005 | 411 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2013 | 2819 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2007 | 1620 | 0.050 |
Why?
|
| DNA, Viral | 2 | 2001 | 694 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2021 | 16 | 0.050 |
Why?
|
| Growth Hormone | 1 | 2002 | 226 | 0.050 |
Why?
|
| Testis | 1 | 2005 | 717 | 0.050 |
Why?
|
| Ecdysone | 1 | 2000 | 5 | 0.050 |
Why?
|
| Cold Temperature | 1 | 2021 | 121 | 0.050 |
Why?
|
| Cell Adhesion | 2 | 2017 | 1008 | 0.050 |
Why?
|
| Tetracycline | 1 | 2000 | 90 | 0.050 |
Why?
|
| Adiponectin | 1 | 2021 | 163 | 0.050 |
Why?
|
| DNA, Fungal | 1 | 2000 | 127 | 0.050 |
Why?
|
| Pigmentation | 1 | 1999 | 47 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2002 | 4053 | 0.040 |
Why?
|
| Cell Growth Processes | 2 | 2010 | 342 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 29902 | 0.040 |
Why?
|
| Adipocytes | 1 | 2021 | 305 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 2216 | 0.040 |
Why?
|
| Ligands | 1 | 2002 | 995 | 0.040 |
Why?
|
| Middle Aged | 3 | 2017 | 86204 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 1999 | 213 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 3101 | 0.040 |
Why?
|
| Professional Practice | 1 | 2018 | 82 | 0.040 |
Why?
|
| Fibrosis | 1 | 2021 | 793 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2013 | 3821 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2010 | 3518 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 1213 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2016 | 2054 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 1999 | 798 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2017 | 348 | 0.040 |
Why?
|
| Research Personnel | 1 | 2018 | 156 | 0.040 |
Why?
|
| Body Weight | 1 | 2021 | 1293 | 0.030 |
Why?
|
| Sirolimus | 1 | 2000 | 814 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 4557 | 0.030 |
Why?
|
| Students | 1 | 2018 | 324 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2001 | 1203 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2016 | 4804 | 0.030 |
Why?
|
| Female | 2 | 2017 | 141928 | 0.030 |
Why?
|
| Neoplasm Metastasis | 3 | 2012 | 5112 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 1029 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 4757 | 0.030 |
Why?
|
| Alleles | 1 | 2000 | 2437 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 7548 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2017 | 419 | 0.030 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2016 | 355 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 1062 | 0.030 |
Why?
|
| DNA Repair | 1 | 2001 | 1872 | 0.030 |
Why?
|
| Internet | 1 | 2018 | 706 | 0.030 |
Why?
|
| Aged | 2 | 2017 | 70117 | 0.030 |
Why?
|
| Genes, ras | 1 | 1996 | 667 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2002 | 5637 | 0.030 |
Why?
|
| DNA | 1 | 2001 | 2693 | 0.030 |
Why?
|
| Hydroxamic Acids | 1 | 2016 | 442 | 0.030 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2013 | 85 | 0.030 |
Why?
|
| Jagged-1 Protein | 1 | 2013 | 101 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2016 | 11965 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 208 | 0.030 |
Why?
|
| Transcriptome | 1 | 2021 | 1859 | 0.030 |
Why?
|
| Snail Family Transcription Factors | 1 | 2012 | 120 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2011 | 10331 | 0.030 |
Why?
|
| Models, Biological | 2 | 2013 | 3254 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 591 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2013 | 886 | 0.020 |
Why?
|
| Adult | 1 | 2017 | 77950 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2010 | 214 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2016 | 1299 | 0.020 |
Why?
|
| RNA Interference | 1 | 2013 | 1408 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2011 | 37905 | 0.020 |
Why?
|
| Solubility | 1 | 2008 | 242 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2000 | 568 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2010 | 652 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2008 | 682 | 0.020 |
Why?
|
| Injections | 1 | 2008 | 285 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 4821 | 0.020 |
Why?
|
| Antibodies, Neoplasm | 1 | 2008 | 259 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2007 | 201 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2013 | 1271 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 703 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 1487 | 0.020 |
Why?
|
| Dasatinib | 1 | 2010 | 862 | 0.020 |
Why?
|
| Adenine | 2 | 2001 | 631 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 5687 | 0.020 |
Why?
|
| Protein Transport | 1 | 2007 | 734 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2008 | 584 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 2944 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 1489 | 0.020 |
Why?
|
| Binding Sites | 2 | 2001 | 2171 | 0.020 |
Why?
|
| Taxoids | 1 | 2008 | 967 | 0.020 |
Why?
|
| Cell Line | 1 | 2012 | 5114 | 0.020 |
Why?
|
| Protein Binding | 2 | 2001 | 3438 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2008 | 1869 | 0.020 |
Why?
|
| Bacteriophage M13 | 1 | 2001 | 15 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 2927 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2001 | 300 | 0.010 |
Why?
|
| Biomarkers | 1 | 2013 | 5047 | 0.010 |
Why?
|
| Bacteriophage phi X 174 | 1 | 2000 | 7 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 2508 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2001 | 549 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 2000 | 342 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 4078 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2000 | 575 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2008 | 9180 | 0.010 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 1996 | 108 | 0.010 |
Why?
|
| Codon | 1 | 1996 | 241 | 0.010 |
Why?
|
| Guanine | 1 | 1996 | 151 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1996 | 515 | 0.010 |
Why?
|
| Kinetics | 1 | 1996 | 2049 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 10035 | 0.010 |
Why?
|